Pancreatic Cancer Research

ResearcherTulane UniversityActive in the last 2 years

Rachel Ε. Neale

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7162-0854; OpenAlex author ID A5077862296. Sources: OpenAlex.

Their work

Papers
65 (first author 3, last author 24)
Trials
0
Grants
0
Labs led
1
Collaborators
131
Papers, trials and grants by year

2013: 3 papers · 2014: 3 papers · 2015: 7 papers · 2016: 11 papers · 2017: 2 papers · 2018: 4 papers · 2019: 3 papers · 2020: 10 papers · 2021: 4 papers · 2022: 3 papers · 2023: 2 papers · 2024: 3 papers · 2025: 2 papers · 2026: 8 papers

Papers 50 of 65

  1. Absolute risk of pancreatic cancer in people with acute pancreatitis - theAustralian experience. Co-author DOI 10.1016/j.hpb.2026.05.011↗
  2. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models. Co-author DOI 10.1038/s41698-026-01479-x↗
  3. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  4. Factors Associated With Pancreatectomy Among Australians With Pancreatic Cancer: A Population-Based Study. Last author DOI 10.1111/ans.70788↗
  5. Clinical Decision Support Tool for Early Pancreatic Cancer Detection in Primary Care: Simulation Study. Co-author DOI 10.2196/79209↗
  6. Decision support tools for pancreatic cancer detection: external validation in Australian primary care - a retrospective cohort study. Co-author DOI 10.3399/bjgp.2025.0328↗
  7. The sensitivity of decision support tools for identifying patients with pancreatic cancer: an observational study. Co-author DOI 10.3399/bjgpo.2025.0142↗
  8. Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals Co-author DOI 10.64898/2026.04.21.26351329↗
  9. Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery. Co-author DOI 10.1016/j.pan.2025.09.029↗
  10. Allelic effects on KLHL17 expression underlie a pancreatic cancer genome-wide association signal at chr1p36.33. Co-author DOI 10.1038/s41467-025-59109-2↗
  11. Association between unstable diabetes mellitus and risk of pancreatic cancer. Last author DOI 10.1016/j.pan.2023.11.009↗
  12. Predicting the risk of pancreatic cancer in women with new-onset diabetes mellitus. Last author DOI 10.1111/jgh.16503↗
  13. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  14. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  15. The Unmet Needs of Pancreatic Cancer Carers Are Associated with Anxiety and Depression in Patients and Carers. Co-author DOI 10.3390/cancers15225307↗
  16. The association between diabetes mellitus of different durations and risk of pancreatic cancer: an Australian national data-linkage study in women. Last author DOI 10.1016/j.canep.2022.102266↗
  17. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2021.11.005↗
  18. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2022.01.011↗
  19. A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer. Co-author DOI 10.1016/j.ajhg.2021.09.002↗
  20. A decision support tool for the detection of pancreatic cancer in general practice: A modified Delphi consensus. Last author DOI 10.1016/j.pan.2021.08.007↗
  21. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  22. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  23. Incorporating multiple sets of eQTL weights into gene-by-environment interaction analysis identifies novel susceptibility loci for pancreatic cancer. Co-author DOI 10.1002/gepi.22348↗
  24. Supporting patients and carers affected by pancreatic cancer: A feasibility study of a counselling intervention. Last author DOI 10.1016/j.ejon.2020.101729↗
  25. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2019.09.002↗
  26. Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: A population-based … Last author DOI 10.1016/j.pan.2020.07.405↗
  27. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djz246↗
  28. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  29. Associations between Genetically Predicted Blood Protein Biomarkers and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0091↗
  30. Genome-Wide Gene-Diabetes and Gene-Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia. Co-author DOI 10.1158/1055-9965.epi-20-0275↗
  31. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  32. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. Co-author DOI 10.1371/journal.pone.0243312↗
  33. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. Co-author DOI 10.1016/j.hpb.2018.08.016↗
  34. Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy155↗
  35. Analysis of Heritability and Genetic Architecture of Pancreatic Cancer: A PanC4 Study. Co-author DOI 10.1158/1055-9965.epi-18-1235↗
  36. Association between pancreatic cancer patients' perception of their care coordination and patient-reported and survival outcomes. Last author DOI 10.1017/s1478951517000608↗
  37. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  38. Biliary Stenting in Patients With Pancreatic Cancer: Results From a Population-Based Cohort Study. Last author DOI 10.1097/mpa.0000000000000960↗
  39. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival. Last author DOI 10.1111/ajco.12862↗
  40. Anxiety, depression and quality of life in people with pancreatic cancer and their carers. First author DOI 10.1016/j.pan.2017.01.008↗
  41. Dietary acrylamide and the risk of pancreatic cancer in the International Pancreatic Cancer Case-Control Consortium (PanC4). Co-author DOI 10.1093/annonc/mdw618↗
  42. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study. Last author DOI 10.1007/s00520-016-3212-4↗
  43. Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study. Last author DOI 10.1007/s10552-016-0824-4↗
  44. Determinants of Outcomes Following Resection for Pancreatic Cancer-a Population-Based Study. Last author DOI 10.1007/s11605-016-3157-4↗
  45. Association between family cancer history and risk of pancreatic cancer. Last author DOI 10.1016/j.canep.2016.10.005↗
  46. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study. Last author DOI 10.1016/j.pan.2016.06.010↗
  47. Pancreatic cancer. Co-author DOI 10.1038/nrdp.2016.22↗
  48. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Co-author DOI 10.1097/mpa.0000000000000392↗
  49. Using a Delphi process to determine optimal care for patients with pancreatic cancer. Last author DOI 10.1111/ajco.12450↗
  50. Beyond survivorship? A discursive analysis of how people with pancreatic cancer negotiate identity transitions in their health. Co-author DOI 10.1177/1359105315592050↗

Closest collaborators

The 25 strongest of 131 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neil Donald Merrett · 18 shared papers, 2015–2025 · strength 1.62
  2. Daniel Gerald Croagh · 10 shared papers, 2019–2026 · strength 1.53
  3. Mary A. Waterhouse · 10 shared papers, 2015–2026 · strength 1.37
  4. John Raymond Zalcberg · 8 shared papers, 2019–2026 · strength 1.15
  5. Vanessa L. Beesley · 13 shared papers, 2015–2023 · strength 0.98
  6. Monika Janda · 12 shared papers, 2015–2023 · strength 0.87
  7. David Goldstein · 12 shared papers, 2016–2020 · strength 0.86
  8. Elizabeth A. Burmeister · 11 shared papers, 2015–2022 · strength 0.85
  9. Helen M. Gooden · 11 shared papers, 2015–2023 · strength 0.80
  10. Javiera Martínez-Gutiérrez · 3 shared papers, 2026 · strength 0.79
  11. Silja Schrader · 3 shared papers, 2026 · strength 0.79
  12. Jon D. Emery · 3 shared papers, 2026 · strength 0.79
  13. Sitwat Ali · 4 shared papers, 2022–2026 · strength 0.78
  14. Ashika D. Maharaj · 6 shared papers, 2019–2025 · strength 0.70
  15. Liane Ioannou · 6 shared papers, 2019–2025 · strength 0.70
  16. Charles H. C. Pilgrim · 6 shared papers, 2019–2025 · strength 0.70
  17. Sue Evans · 6 shared papers, 2019–2025 · strength 0.70
  18. Kate White · 6 shared papers, 2019–2025 · strength 0.70
  19. Harvey A. Risch · 13 shared papers, 2013–2020 · strength 0.68
  20. James G. Kench · 5 shared papers, 2019–2025 · strength 0.61
  21. Savio George Barreto · 3 shared papers, 2015–2026 · strength 0.58
  22. David Goldstein · 5 shared papers, 2015–2025 · strength 0.57
  23. John Albert Windsor · 3 shared papers, 2021–2026 · strength 0.56
  24. Andrew J. Metz · 3 shared papers, 2021–2026 · strength 0.56
  25. Bridie S. Thompson · 3 shared papers, 2021–2026 · strength 0.51

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.